EP3578169
LYFJASAMSETNINGAR SEM INNIHALDA 4-{(1 R)-2-[(6-{2-[(2,6-DÍKLÓRÓBENSÍL)OXÝ]ETOXÝ}HEXÝL)AMÍNÓ]-1- HÝDROXÝETÝL}-2-(HÝDROXÝMETÝL)FENÓL
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
26.2.2009EP published:
26.6.2024EP application number:
19175120.5
EP translation filed:
29.8.2024Grant published:
15.10.2024EPO information:
European Patent Register
Max expiry date:
25.2.2029Expiry date:
25.2.2027Next due date:
28.2.2027
Title in English:
PHARMACEUTICAL FORMULATIONS COMPRISING 4-{(1 R)-2-[(6-{2-[(2,6-DICHLOROBENZYL)OXY]ETHOXY}HEXYL)AMINO]-1-HYDROXYETHYL}-2-(HYDROXYMETHYL)PHENOLLanguage of the patent:
English
Timeline
Today
26.2.2009EP application
26.6.2024EP Publication
29.8.2024Translation submitted
15.10.2024Registration published
25.2.2027Expires
Owner
Name:
Glaxo Group LimitedAddress:
GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, GB
Inventor
Name:
BAKER, DarrellAddress:
Uxbridge, Middlesex UB11 1BT, GB
Name:
BRUCE, MarkAddress:
Stevenage, Hertfordshire SG1 2NY, GB
Name:
THOMAS, MarianAddress:
Ware, Hertfordshire SG12 ODP, GB
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Classification
Categories:
A61K 9/00, A61K 31/58, A61K 31/138, A61K 45/06, A61P 11/00, A61P 11/06, A61P 11/08, A61P 37/08, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 17
Paid: 29.1.2025
Expires: 25.2.2026
Payer: Árnason Faktor ehf.
Number: 18
Paid: 16.2.2026
Expires: 25.2.2027
Payer: Árnason Faktor ehf.